Leading Pharma’s U.S.-based manufacturing facility develops and manufactures oral solid dose products under the Leading label.

This 53,000 square foot site holds a DEA license for the manufacturing and storage of Schedule III-V controlled substances and also serves as a warehouse and distribution center. In addition, this FDA-approved facility offers cGMP on-site granulation, compression, and packaging and has the capacity to produce 2.5 million tablets per shift, or to package up to 2 billion units per year, across its five lines.